CAS No. |
27848-84-6 |
中文名称 |
5-溴烟酸(((6aR,9R,10aS)-10a-甲氧基-4,7-二甲基-4,6,6a,7,8,9,10,10a-八氢吲哚并[4,3-fg]喹啉-9-基)甲基)酯 |
英文名称 |
((6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methyl 5-bromonicotinate |
别名 |
KBio2_001850 | Pharmakon1600-01501133 | Sermion (TN) | 10-Methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyrindinecarboxylate (ester) | duracebrol | NICERGOLINE [MART.] | Tox21_110810 | BSPBio_003533 | DTXSID7045607 | MFCD00869626 | Nicergoline 1.0 mg/ |
标准英文名 |
((6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methyl 5-bromonicotinate |
MDL No. |
MFCD00869626 |
分子式 |
C24H26BrN3O3 |
分子量 |
484.39
|
精确分子量 |
483.12
|
SMILES |
CO[C@]12C[C@@H](COC(=O)C3=CN=CC(Br)=C3)CN(C)[C@@H]1CC1=CN(C)C3=CC=CC2=C13 |
标准SMILES |
CO[C@]12C[C@H](CN(C)[C@@H]1CC1=CN(C)C3=CC=CC2=C13)COC(=O)C1C=C(Br)C=NC=1 |
用途 |
Nicergoline is used for the treatment of cerebrovascular disorders, dementia, and dizziness; it improves cerebral circulation by dilating resistance vessels and acts as a selective α1A-adrenergic receptor antagonist; it enhances cerebral metabolism and electroencephalographic activity, improves cognitive function in Alzheimer’s disease models, and promotes neurogenesis; it also alleviates microglia- and astrocyte-induced neuronal cell death, suppresses proinflammatory cytokine production and oxidative stress, and modulates hippocampal cell activity via the PI3K/AKT signaling pathway. |
InChIKey |
YSEXMKHXIOCEJA-FVFQAYNVSA-N |